Review Article
Volume 13 Issue 5 - 2021
Is Stellate Ganglion Block an Alternative Treatment for Posttraumatic Stress Disorder?
Hani Raoul Khouzam*
Staff Psychiatrist, PTSD Treatment Program, VA Northern California Health Care System (VANCHCS), Mather and Clinical Professor of Psychiatry and Medicine, UC Davis Health, Sacramento, California, USA
*Corresponding Author: Hani Raoul Khouzam, Staff Psychiatrist, PTSD Treatment Program, VA Northern California Health Care System (VANCHCS), Mather California, USA.
Received: March 19, 2021; Published: April 09, 2021




Abstract

Stellate Ganglion Block, also known as cervical sympathetic block, is an outpatient procedure which is approved for diagnosing and treating complex pain syndromes affecting multiple locations in the head, neck, face, chest or arms. Although, there are several evidence based and effective pharmacological and psychological treatments that are available for the treatment of posttraumatic stress disorder. Many patients do not respond or do not adhere to these effective treatments due to the chronicity of their illness, the occurrence of adverse effects or the presence of social stigma associated with receiving psychotherapy and psychopharmacological treatments. This article review the definition of posttraumatic stress disorder, and its currently available conventional treatments, then summarizes the historical background, the rational and the possible risks associated with the use of Stellate Ganglion Block as a potential alternative treatment modality for posttraumatic stress disorder. There is still an urgent need to undergo rigorous welldesigned randomized double-blind and placebo-controlled research clinical trials to confirm the utility of Stellate Ganglion Block as an alternative evidence-based treatment modality for posttraumatic stress disorder.

Keywords: Posttraumatic Stress Disorder; Stellate Ganglion Block; Psychotherapy; Psychopharmacology; Treatment; Guidelines

References

  1. American Psychiatry Association. “Diagnostic and Statistical Manual of Mental Disorders (5th edition)”. Arlington: American Psychiatric Publishing (2013): 265-280.
  2. Khouzam HR. “Pharmacotherapy for Posttraumatic Stress Disorder”. Journal of Clinical Outcomes Management 20 (2013): 21-33.
  3. Pietrzak RH., et al. “Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions”. Journal of Anxiety Disorders3 (2011): 456-465.
  4. Goldstein RB., et al. “The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III”. Social Psychiatry and Psychiatric Epidemiology8 (2016):1137-1148.
  5. Kisely S., et al. “The prevalence of depression and anxiety disorders in indigenous people of the Americas: A systematic review and meta-analysis”. Journal of Psychiatric Research 84 (2017): 137-152.
  6. Lake J. “The integrative management of PTSD: A review of conventional and CAM approaches used to prevent and treat PTSD with emphasis on military personnel”. Advances in Integrative Medicine 2 (2015): 13-23.
  7. Armenta RF., et al. “Millennium Cohort Study team. Factors associated with persistent posttraumatic stress disorder among U.S. military service members and veterans”. BMC Psychiatry1(2018): 48.
  8. Hamner MB, et al. “Treatment-resistant posttraumatic stress disorder: strategies for intervention”. CNS Spectrum10 (2004): 740-752.
  9. Difede J., et al. “Evidence-based treatment of post-traumatic stress disorder”. Annual Review of Medicine 65 (2014): 319-332.
  10. Hoge CW. “Interventions for war-related posttraumatic stress disorder: meeting veterans where they are”. Journal of the American Medical Association5 (2011): 549-551.
  11. Wang HR., et al. “Anticonvulsants to treat post-traumatic stress disorder”. Human Psychopharmacology 5 (2014): 427-433.
  12. Stecker T., et al. “Treatment-seeking barriers for veterans of the Iraq and Afghanistan conflicts who screen positive for PTSD”. Psychiatric Services3 (2013): 280-283.
  13. Summers MR and Nevin RL. “Stellate Ganglion Block in the Treatment of Post-traumatic Stress Disorder: A Review of Historical and Recent Literature”. Pain Practice4 (2017): 546-553.
  14. Navaie M., et al. “Use of stellate ganglion block for refractory post‐traumatic stress disorder: a review of published cases”. Journal of Anesthesia and Clinical Research4 (2014): 403.
  15. Lebovits AH., et al. “Reflex sympathetic dystrophy and posttraumatic stress disorder. Multidisciplinary evaluation and treatment”. Clinical Journal of Pain 6 (1990): 153-157.
  16. Takano M., et al. “Unexpected beneficial effect of stellate ganglion block in a schizophrenic patient”. Canadian Journal of Anesthesia 49 (2002): 758-759.
  17. Lipov EG., et al. “Cervical sympathetic blockade in a patient with post‐traumatic stress disorder: a case report”. Annals of Clinical Psychiatry 20 (2008): 227-228.
  18. Lipov E. “In search of an effective treatment for combat‐related post‐traumatic stress disorder (PTSD): can the stellate ganglion block be the answer?” Pain Practice 10 (2010): 265-266.
  19. McLean B. “Safety and patient acceptability of stellate ganglion blockade as a treatment adjunct for combat‐related post‐traumatic stress disorder: a quality assurance initiative”. Cureus 7 (2015): e320.
  20. Mulvaney SW., et al. “Neurocognitive performance is not degraded after stellate ganglion block treatment for post‐traumatic stress disorder: a case series”. Military Medicine 180 (2015): e601-e604.
  21. Hickey A., et al. “Stellate ganglion block for the treatment of posttraumatic stress disorder”. Psychiatric Annals 43 (2013): 87-92.
  22. Rae Olmsted KL., et al. “Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: A randomized clinical trial”. Journal of the American Medical Association Psychiatry2 (2020): 130-138.
  23. Lipov E and Ritchie EC. “A review of the use of stellate ganglion block in the treatment of PTSD”. Current Psychiatry Report 8 (2015): 599.
  24. Averill CL., et al. “Of Forests and Trees: Bridging the Gap Between Neurobiology and Behavior in Posttraumatic Stress Disorder”. Biological Psychiatry Cognitive Neuroscience Neuroimaging2 (2020): 135-137.
  25. Lipov E., et al. “Modulation of NGF by cortisol and the Stellate Ganglion Block - is this the missing link between memory consolidation and PTSD?” Medical Hypotheses6 (2012): 750-753.
  26. Yeo J and Jeon Y. “Effects of stellate ganglion block on sedation as assessed by bispectral index in normal healthy volunteers”. Pain Physician2 (2015): 173-178.
  27. Abdi S., et al. “A new and easy technique to block the stellate ganglion”. Pain Physician3(2004): 327-331.
  28. Mulvaney SW et al. “Clinical Guidelines for Stellate Ganglion Block to Treat Anxiety Associated with Posttraumatic Stress Disorder”. Journal of Special Operations Medicine2 (2015): 79-85.
  29. Ghai A., et al. “Stellate ganglion blockade-techniques and modalities”. Acta Anaesthesiologica Belgica1 (2016): 1-5.
  30. , et al. “Guideline watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder”. Focus 7.2 (2009): 204-213.
Citation: Hani Raoul Khouzam. “Is Stellate Ganglion Block an Alternative Treatment for Posttraumatic Stress Disorder?”. EC Neurology 13.5 (2021): 08-13.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 24, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk